NCT05541484View on ClinicalTrials.gov

Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 14, 2022

Primary Completion Date

December 23, 2023

Study Completion Date

December 23, 2023

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

SGLT2 inhibitor

See above.

DEVICE

Biosense Breath Ketone Analyzer

The hand-held device tests ketones in exhaled breath

Trial Locations (1)

63110

Washington University, St Louis

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Washington University School of Medicine

OTHER